Continuous testosterone alone, delivered by subcutaneous implant, was effective for the relief of hormone deficiency symptoms in both pre- and post-menopausal patients. The Menopause Rating Scale (MRS, proved a valuable tool in the measurement of the beneficial effects of testosterone therapy in both cohorts.